Summary A nested case-control study was undertaken in the Maribo County cohort of 27,811 women with negative Pap smears. Sixty women who later developed invasive cervical cancer constituted the cases, and five matched controls were selected from the cohort for each case. A total of 633 previous, negative smears for the cases and controls were reviewed independently by two pathologists. The review showed misclassification to be frequent in these smears collected in the period 1966-82. Thirty-five smears were considered positive at the review. The misclassification was differential in respect to the women's later disease status. The odds ratio for patients compared with controls for having at least one positive smear was 22.12 
dyskeratosis, herpes virus changed cells and hyperkeratosis were equally rare in smears from patients and controls. The Maribo County data indicate that the fraction of preventable cases of invasive cervical cancer in women aged 30-64 within the first 5 years after a negative smear could be increased from 62-72% to 83-86%, if misclassification of true positive smears could be eliminated. As a rough estimate, this would be at the cost of a 2% increase in the work load. It should be remembered that there is a large element of extrapolation in applying these results based on relatively poor quality specimens from 1966-82 as compared to a modem screening service.
Women from Maribo County, Denmark, were followed in a cohort study to evaluate the risk of developing invasive cervical cancer after cytologically normal Pap smears (Lynge & Poll, 1986) . The region had an organised screeing programme and the study included data both on smears taken in the programme and on smears taken in the clinical work. The study showed that the five-year risk of developing invasive cervical cancer was 48% lower in women after one negative smear than in women from control regions where screening was not offered, and the five-year risk in women after 2-4 negative smears was 69% lower.
These results from Maribo County cohort thus illustrate the overall protective effect of cervical cancer screening found in the IARC collaborative study (IARC working group, 1986 ), of which it was a part. Cervical cancer was, however, not completely eliminated as a disease, and 60 cases of invasive cervical cancers were diagnosed during the years 1966-84 in the Maribo County cohort of 27,811 women, who originally had negative smears. Could these cancer cases also have been prevented, and a higher efficiency of the widespread screening activity thus have been achieved? The quality of the cytopathology is an important element in an answer to this question, and review of Pap smears from cervical cancer patients has previously revealed misclassification, e.g. Mitchell et al. (1990) .
The Maribo County cohort came from a region where the 98,000 negative smears belonging to the cohort members were stored in one place. We should accurately reflect the underlying histology, and it should contain cells from the whole of the transformation zone (Coleman et al., in press (Breslow & Day, 1980 Table II shows the result of the two independent reviews of the 633 originally negative smears. The two pathologists agreed in their evaluations for 427 ( = 68%). Only 371 (= 59%) smears were considered negative by both pathologists at the review. A consensus review was made for the 68 smears considered positive by one pathologist only. As a result of the reevaluation 22 smears were classified as positive and 46 smears as negative. Table III shows the distribution of smears from case and control persons, respectively, by the main diagnostic group as given by each of the two pathologists, by combining the reviews from the two pathologists to give the most severe diagnosis, and from the consensus review. The percentage of positive smears was higher for smears from cases, in the range 16-34%, than for smears from controls, in the range 2-9%, in all four reviews. There was less variation between the smears from cases and from controls in the percentages of unsatisfactory, which varied between 13-25% among smears from cases and 15-29% among smears from controls. (Mitchell et al., 1988) to 64% (Attwood et al., 1985) previously reported in the predominantly small series of patients with invasive cervical cancer for whom the previous negative smears have been reviewed (Rylander, 1977; Gad & Koch, 1978; Berkowitz et al., 1979; Berkeley et al., 1980; Holman et al., 1981; Morell et al., 1982; Walker et al., 1983 : Paterson et al., 1984 Gay et al., 1985; Attwood et al., 1985; Graff et al., 1987; Mitchell et al., 1988; Mitchell et al., 1990) .
Women with invasive cervical cancer had an increased risk compared with controls for having at least one misclassified positive smear. The risk estimate varied, however, 10-fold, from 30.82 in the review made by pathologist A, to 2.62 in the review made by pathologist B. The answer to the initial question in this study, whether misclassification of Pap smears is in fact differential in respect to later disease status, is therefore yes, but the size of the risk estimate is highly dependent on the reviewer. The risk estimate was 22.12 in the consensus review.
In addition to looking for misclassified positive smears, the analysis also included estimation of the risk for misclassification for referral to diagnostic follow up. In this respect both positive and unsatisfactory smears were considered misclassified, as both types of smears should initiate diagnostic follow up. The risk estimates for patients com- We were thus not able to identify specific characteristics for misclassified smears belonging to future patients compared with misclassified smears belonging to women who remained disease free. Furthermore, only a minority of the smears was found to be positive for koilocytosis/dyskeratosis, herpes virus changed cells, or hyperkeratosis, and the risks for the presence of these conditions were not increased in patients compared with controls. In the control group, 4% of the originally negative smears were considered positive for koilocytosis/dyskeratosis at the review. This corresponds well with the previously reported proportions of HPV-related morphological signs of 0-12.3% in smears from women without CIN (Sanjose et al., 1992) .
Misclassification indicates the existence of avoidable cases of invasive cervical cancer, and it is possible from the Maribo County data to estimate the potential improvement of the protective effect of a screening programme, if the misclassification of positive smears could be eliminated. Table  VIII shows the estimates for the fraction of preventable cases of invasive cervical cancer in women 30-64 years within the first 5 years after one and 2-4 negative smears, respectively. The baseline used for comparison was the incidence of invasive cervical cancer in a similar population without screening, giving a 5-year probability of 0.0029 (Lynge & Poll, 1986 ). For one negative smear, the estimated fraction of prevented cases was 48% based on the registered cases. Invasive growth was, however, not confirmed in all of these cases, and the 'true' estimate for the fraction of prevented cases was thus 62%. As the baseline used for comparison represents symptomatic, clinically detected cases, it is assumed here that a histologic review would not change the baseline. If none of the positive smears from the confirmed cases had been missed, the fraction of preventable cases would have been 86%. The equivalent fraction for women with 2-4 negative smears would have been 83%. The potential impact of improved cytology was, as expected, greater in women with one -wegative smear only, 24% (= 86%-62%), than in women with 2-4 negative smears, 11% ( = 83%-72%). The instability of these estimates due to small numbers should be noted. Figure 1 shows the incidence curves based on which the disease probabilities have been calculated.
Screening for cervical cancer has been widespread in many countries for the last 20-30 years. In Denmark, women have on average a smear taken every second year (Sundhedsstryrelsen, 1986) , and the incidence of invasive cervical cancer has decreased, but is still at a level of 16.4 per 100,000 (World Standard Population) (Storm et al., 1991) . Several measures on the organisational level can contribute to improve the efficiency of screening programmes (Chamberlain, 1986 ). The present study indicates that with an improved cytopathology which eliminates misclassification of positive smears the proportion of prevented cancers increases from 62-72% to 83-86%. As a rough estimate, this can be achieved with a 2% increase in the work load. The study also indicates that although the protection might be even better if all unsatisfactory smears were correctly identified, this would imply a 31 % increase in the cost, and would thus be unacceptable for both ethical and economic reasons. It should be remembered that there is a large element of extrapolation in applying these results based on relatively poor quality specimens from 1966-82 as compared to a modern screening service.
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